Skip to main content
Equibles

Tower Research Capital LLC (TRC)

Position in MBRX — Moleculin Biotech, Inc.

CIK 1533421 NEW YORK, NY
Back to MBRX Full portfolio

Position in MBRX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$9,803
+$5,601 QoQ
Shares Held
3,514
+91.5% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 18 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBRX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Tower Research Capital LLC (TRC) holds $49,739,988 across 466 Biotechnology names. MBRX ranks #309 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 4,547 $4,218,570
2 BBIO
BridgeBio Pharma, Inc.
 38,206 $2,845,582
3 ARWR
Arrowhead Pharmaceuticals, Inc.
 34,537 $2,815,110
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 4,292 $2,131,964
5 MDGL
Madrigal Pharmaceuticals, Inc.
 3,927 $2,108,602
6 AXSM
Axsome Therapeutics, Inc.
 6,437 $1,575,584
7 INSM
INSMED Inc
 10,927 $1,165,036
8 ROIV
Roivant Sciences Ltd.
 32,746 $1,158,880

All Filings in MBRX

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $9,803 3,514
2026-03-31 $4,202 1,835
2025-12-31 $4,610 1,393
2025-09-30 $4,441 8,380
2025-06-30 $1,184 3,921
2025-03-31 $1,312 1,348
2024-12-31 $6,840 4,024
2024-09-30 $5,143 1,811
2024-06-30 $7,022 1,995
2024-03-31 $3,670 621
2023-12-31 $6,178 7,201
2023-09-30 $6,122 14,305
2023-06-30 $8,322 14,374
2023-03-31 $11,835 12,329
2022-12-31 $5,676 5,355
2022-09-30 $10,358 9,772
2022-06-30 $6,061 4,180
2022-03-31 $7,459 4,191
2021-09-30 $120 40
2021-06-30 $9,222 2,513
2020-12-31 $7,156 8,979